Arca
Skip to content
Tools
Tools

Vasopressin receptor

Family in Homo sapiens that 4 drugs act on.

  • Drugs that act on it: 4
  • Approved: 3
  • In phases 1 to 3: 1
  • Sponsors: 3
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on AVPR1A, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 4

Approved3

  • Vasopressin
  • Desmopressin
  • Lypressin

Phase 30

    Phase 21

    • Argipressin tannate

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Vasopressin receptor agonist.
      VasopressinApprovedPH HealthProtein or peptideAgonist66
      DesmopressinBoxed warningApprovedFerring PharmaceuticalsProtein or peptideAgonist16
      LypressinApprovedNovartis PharmaceuticalsProtein or peptideAgonist8
      Argipressin tannatePhase 2—Protein or peptideAgonist1

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 22 in all, from ClinicalTrials.gov.
      The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older AdultsVasopressinNot applicableRecruitingPolytechnic University of SantarémOct 23, 2026
      FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal PolypsDesmopressinNot applicableNot yet recruitingServices Institute of Medical Sciences, PakistanOct 2, 2026
      Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face AttentionVasopressinNot applicableRecruitingUniversity of Electronic Science and Technology of ChinaSep 24, 2026
      Biological Profiles of Neuropeptides, Neurotrophins and miRNA in MigraineVasopressin—Enrolling by invitationNordlandssykehuset HFSep 21, 2026
      Bedtime Device Restriction and Desmopressin in PMNE.Desmopressin, VasopressinNot applicableRecruitingAl-Azhar UniversityAug 20, 2026
      Terlipressin vs Placebo to Reduce Bleeding in Fibroid SurgeryLypressin, VasopressinNot applicableNot yet recruitingSevil CankayaAug 5, 2026
      Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region TumorsDesmopressin, VasopressinPhase 4Enrolling by invitationZhaoyun ZhangJul 17, 2026
      Effect of Adding Vasopressin on Cardiac Output, Blood Pressure, Diuresis, and Tissue Perfusion Indices in Patients With Septic ShockVasopressin—Not yet recruitingAssistance Publique - Hôpitaux de ParisJul 13, 2026
      Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)VasopressinPhase 4Not yet recruitingMethodist Healthcare System of San AntonioJun 26, 2026
      International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of HyponatremiaDesmopressin—Enrolling by invitationRochester General HospitalMay 8, 2026
      Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver TransplantationLypressinNot applicableRecruitingIstanbul Medipol University HospitalDec 26, 2025
      Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal DysfunctionLypressinNot applicableNot yet recruitingGeneral Hospital of Shenyang Military RegionNov 26, 2025
      Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNEDesmopressinPhase 3RecruitingMansoura UniversitySep 30, 2025
      DDAVP Effect by TEG6 in Cardiac SurgeryDesmopressin—RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sSep 18, 2025
      Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic ShockArgipressin tannatePhase 3RecruitingCentre Hospitalier Universitaire DijonJul 14, 2025
      Uroflowmetry and Nocturnal EnuresisDesmopressin—Active, not recruitingFurkan Adem CanbazJun 19, 2025
      Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With DesmopressinDesmopressinPhase 3Not yet recruitingImam Abdulrahman Bin Faisal UniversityJun 10, 2025
      Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney TransplantationLypressinNot applicableActive, not recruitingBeijing Friendship HospitalMar 4, 2025
      Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal SyndromeLypressinPhase 2Active, not recruitingNoorik Biopharmaceuticals AGFeb 13, 2024
      Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal SyndromeLypressinPhase 2RecruitingRiver 2 Renal Corp.May 25, 2023
      HRS-AKI Treatment With TIPS in Patients With CirrhosisLypressinNot applicableRecruitingJena University HospitalApr 26, 2022
      The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic TourniquetsLypressinNot applicableRecruitingWael Elbanna ClinicMar 4, 2022

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2363078, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.